MAUDE MDR 2021273

MDR report key
2021273
Report number
1061932-2011-00148
Event key
0
Event type
3
Date of event
2011-02-11
Date received
2011-03-17
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
0
Initial report to FDA
3
Event location
0

Manufacturer Contact#

Contact
MS NORA ZEROUNIAN
Address
250 S KRAEMER BOULEVARD BREA CA 92821 US
Phone
714-714-7149
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1COULTER LH 750 ANALYZERAUTOMATED DIFFERENTIAL CELL COUNTERBECKMAN COULTER, INC.LOQLH 7506605632N/AY Y

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12011-03-170

Event Narratives#

D

Patient 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) STATING THAT THE COULTER LH 750 ANALYZER GENERATED ERRATIC DIFFERENTIAL RESULTS ON TWENTY-SIX (26) PATIENT SPECIMENS. OF TWENTY-SIX (26) SPECIMENS TWELVE (12) HAD INSTRUMENT GENERATED R (REVIEW RESULT) FLAGS ON THE DIFFERENTIAL PARAMETERS. THE CUSTOMER STATED THAT THE LABORATORY PROTOCOL IS TO RUN THE SPECIMENS IN BATCHES OF FIFTY (50) SPECIMENS, PRECEDED AND FOLLOWED BY A CONTROL. THE OPERATOR NOTICED THAT THE CONTROL RECOVERED OUTSIDE QC LIMITS AND ABORTED THE BATCH RUN AFTER TWENTY SIX (26) SPECIMENS HAD BEEN COMPLETED. NO ERRONEOUS RESULTS WERE REPORTED OUTSIDE THE LABORATORY. THE CUSTOM RERAN THE SPECIMENS ON AN ALTERNATE INSTRUMENT AND VERIFIED THE RESULTS BEFORE REPORTING. THERE WAS NO DEATH, INJURY, OR CHANGE TO PATIENT TREATMENT ASSOCIATED WITH THIS EVENT.

N

Patient 1

THE SPECIMENS WERE COLLECTED IN 5 ML VENOJECT VACUTAINER TUBES AND TRANSPORTED REFRIGERATED AND STORED AT ROOM TEMPERATURE. CONTROLS WERE RUN BEFORE AND AFTER THE INCIDENT AND THE ERROR WAS DISCOVERED BECAUSE THE BATCH CONTROL RECOVERED OUTSIDE QC LIMITS. THE INSTRUMENT IS CURRENTLY WITHIN QC SPECIFICATIONS WITH RESPECT TO CONTROLS (ACCURACY) AND REPRODUCIBILITY (PRECISION). A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED AND REPLACED THE LS PRE-AMP ASSEMBLY AND ADJUSTED THE GAIN, WHICH WAS THE ROOT CAUSE OF THIS EVENT. THE FSE ALSO VERIFIED THE INSTRUMENTS OPERATION. BECKMAN COULTER INC. DOES NOT CLAIM TO IDENTIFY EVERY ABNORMALITY IN ALL SAMPLES. BECKMAN COULTER INC. SUGGESTS USING ALL AVAILABLE FLAGGING OPTIONS TO OPTIMIZE THE SENSITIVITY OF INSTRUMENT RESULTS BASED ON YOUR PATIENT POPULATION. ALL FLAGGING OPTIONS INCLUDE REFERENCE RANGES (H/L), ACTION AND CRITICAL LIMITS, DEFINITIVE FLAGS, SUSPECT FLAGS, PARAMETER CODES, DELTA CHECKS, DECISION RULES AND SYSTEM ALARMS. BECKMAN COULTER INC. RECOMMENDS AVOIDING THE USE OF SINGLE MESSAGES OR OUTPUTS TO SUMMARIZE SPECIMEN RESULTS OR PATIENT CONDITIONS. THERE MAY BE SITUATIONS WHERE THE PRESENCE OF RARE EVENTS MAY FAIL TO TRIGGER A SUSPECT MESSAGE.